CLOs on the Move

Halozyme

www.halozyme.com

 
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. Halozyme advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients` lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE® technology, which can reduce hours-long treatments to a matter of minutes, Halozyme`s commercially-validated solution has touched more than 500,000 patient lives in post-marketing use via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs ...
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million
  • www.halozyme.com
  • 11388 Sorrento Valley Road
    San Diego, CA USA 92121
  • Phone: 858.794.8889

Executives

Name Title Contact Details
Mark Snyder
 Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary Profile
Masaru Matsuda
 SVP, General Counsel, Chief Compliance Officer and Corporate Secretary Profile
Masaru Matsuda
 Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary Profile

Similar Companies

Sinclair Research Center Inc

Sinclair Research Center Inc is a Columbia, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Olive View Medical Center

Olive View Medical Center is a Sylmar, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lung Therapeutics

Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions.

HyperOmics Farma

HyperOmics Farma Inc. is a Montrí©al, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Omicia

Omicia is unlocking the potential of individualized medicine. Our mission is to help researchers and clinicians understand and apply the most relevant information from personal genome sequences, to improve disease management and medical outcomes. Researchers and clinical diagnostic organizations use our solutions to analyze and identify the genetic basis of a variety of conditions, including childhood disease, cancer and cardiovascular disease. Opal™, the leading platform for fast, accurate and flexible genome analysis, enables clinicians, researchers and bioinformaticians alike to derive clinically relevant insights from genomic data. VAAST, our robust novel disease gene finder and variant scoring algorithm, is in use at more than 300 academic and clinical institutions including the NIH, the University of Oxford, the University of Cambridge, Seattle Children’s Research Institute, Institut Pasteur, University of Maryland Institute for Genome Sciences, and UCSF.